13F Filings History of Foresite Capital Management III, LLC

Latest 13F report
Q3 2022 - 14 Nov 2022
Value $
$37,881,000
Signature - Title
James B. Tananbaum - Managing Member
Location
Larkspur, CA
Summary
This page shows a list of all the recent 13F filings made by Foresite Capital Management III, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Foresite Capital Management III, LLC reported 4 stock holdings with total value $37,881,000 as of Q3 2022. Top holdings included ASND, VRNA, NTRA, and CBAY.

Notify me when Foresite Capital Management III, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2022 4 $37,881,000 $0 $0 $0 ASND, VRNA, NTRA, CBAY 13F-HR 14 Nov 2022, 09:28
Q2 2022 4 $27,568,000 $0 $0 $0 ASND, NTRA, CBAY, VRNA 13F-HR 12 Aug 2022, 09:23
Q1 2022 4 $32,815,000 +$2,772,908 $0 +$2,772,908 ASND, NTRA, VRNA, CBAY 13F-HR 13 May 2022, 09:06
Q4 2021 4 $39,499,000 +$26,483,000 -$60,031,000 -$33,548,000 ASND, NTRA, VRNA, CBAY 13F-HR 11 Feb 2022, 15:01
Q3 2021 6 $72,113,000 $0 -$22,596,000 -$22,596,000 ACRS, XLRN, VRNA, CBAY, EPZM 13F-HR 12 Nov 2021, 09:54
Q2 2021 8 $94,339,000 $0 $0 $0 ACRS, NTRA, XLRN, EPZM, FGEN 13F-HR 13 Aug 2021, 18:19
Q1 2021 8 $113,881,000 +$17,722,504 -$16,820,000 +$902,504 ACRS, XLRN, NTRA, FGEN, VRNA 13F-HR 14 May 2021, 19:18
Q4 2020 8 $86,035,000 +$10,995,319 -$69,484,946 -$58,489,627 Oric Pharmaceuticals, Inc., XLRN, NTRA, FGEN, EPZM 13F-HR 16 Feb 2021, 08:46
Q3 2020 10 $134,301,000 +$34,907,636 -$36,229,000 -$1,321,364 MYOK, NTRA, Oric Pharmaceuticals, Inc., XLRN, EPZM 13F-HR 13 Nov 2020, 10:54
Q2 2020 8 $112,465,000 +$34,472,769 -$12,323,000 +$22,149,769 MYOK, BPMC, ORIC, EPZM, NTRA 13F-HR 13 Aug 2020, 10:03
Q1 2020 9 $62,801,000 +$16,617,738 -$87,588,298 -$70,970,560 MYOK, EPZM, BPMC, NTRA, IMMU 13F-HR 14 May 2020, 09:20
Q4 2019 10 $178,435,000 +$2,027,400 -$150,969,936 -$148,942,536 AERI, IMMU, MYOK, EPZM, BOLD 13F-HR 14 Feb 2020, 15:30
Q3 2019 14 $261,893,000 +$14,660,504 -$36,152,170 -$21,491,666 AERI, ALDR, BPMC, IMMU, ASND 13F-HR 13 Nov 2019, 09:03
Q2 2019 18 $304,928,000 +$1,383,459 -$9,706,973 -$8,323,514 AERI, BPMC, ALDR, IMMU, ASND 13F-HR 13 Aug 2019, 10:00
Q1 2019 19 $384,166,000 +$5,351,800 -$27,458,207 -$22,106,407 AERI, IMMU, ALDR, BPMC, ASND 13F-HR 14 May 2019, 10:49
Q4 2018 22 $304,474,000 +$33,142,436 -$36,743,729 -$3,601,293 AERI, IMMU, ALDR, BPMC, RCUS 13F-HR 13 Feb 2019, 17:11
Q3 2018 24 $453,219,000 +$23,524,917 -$16,428,959 +$7,095,958 AERI, IMMU, ALDR, RCUS, MYOK 13F-HR 13 Nov 2018, 14:32
Q2 2018 22 $457,272,000 +$1,789,858 -$41,802,068 -$40,012,210 AERI, IMMU, ALDR, RCUS, AKAOQ 13F-HR 14 Aug 2018, 16:02
Q1 2018 23 $412,116,000 +$46,069,457 -$6,924,430 +$39,145,027 AERI, IMMU, ALDR, AKAOQ, BPMC 13F-HR 15 May 2018, 09:42
Q4 2017 17 $356,346,000 +$17,346,500 -$56,143,841 -$38,797,341 AERI, IMMU, ALDR, BPMC, AIMT 13F-HR 13 Feb 2018, 13:12
Q3 2017 20 $363,051,000 +$75,503,262 -$40,558,665 +$34,944,597 AERI, ALDR, IMMU, BPMC, AKAOQ 13F-HR 13 Nov 2017, 13:41
Q2 2017 26 $306,137,000 +$92,782,100 -$35,171,364 +$57,610,736 AERI, AKAOQ, ALDR, BPMC, AIMT 13F-HR 14 Aug 2017, 13:05
Q1 2017 25 $260,549,000 +$37,075,338 -$59,776,941 -$22,701,603 AERI, ALDR, AKAOQ, AIMT, WVE 13F-HR 12 May 2017, 09:17
Q4 2016 20 $230,122,000 +$61,526,010 -$23,662,147 +$37,863,863 AERI, AKAOQ, ALDR, AIMT, WVE 13F-HR 10 Feb 2017, 16:54
Q3 2016 17 $213,950,000 +$47,505,256 -$37,480,896 +$10,024,360 AERI, ALDR, WVE, AIMT, NTLA 13F-HR 14 Nov 2016, 09:58
Q2 2016 18 $145,736,000 +$38,350,879 -$37,068,726 +$1,282,153 ALDR, AERI, WVE, NTLA, GBT 13F-HR 12 Aug 2016, 15:57
Q1 2016 23 $129,247,000 +$54,069,334 -$923,890 +$53,145,444 ALDR, WVE, AERI, GBT, ZFGN 13F-HR 06 May 2016, 14:57
Q4 2015 17 $105,776,000 $0 $0 $0 WVE, GBT, ALDR, EPZM, ZFGN 13F-HR 11 Feb 2016, 19:05